Haemonetics (HAE) Tops Q1 EPS by 5c, Beats on Revenue
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $87.22 --0%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
SUNE, NSLR, OCTV, More
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
SUNE, NSLR, OCTV, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.14, $0.05 better than the analyst estimate of $1.09. Revenue for the quarter came in at $339 million versus the consensus estimate of $328.92 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nebius soars on second quarter revenue beat
- BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance
- ISS recommends LivePerson stockholders back SoundHound AI deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
